CLOV CLOVER HEALTH INV CORP

Clover Health Promotes Karen Soares to General Counsel

Clover Health Promotes Karen Soares to General Counsel

FRANKLIN, Tenn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Karen Soares as General Counsel, effective October 31, 2023. Karen will serve on Clover’s management team and will report to Andrew Toy, Chief Executive Officer of Clover.

“Karen has been a tremendous asset to Clover over the years, providing strategic legal counsel and partnership as our business has continued to evolve. I’m delighted to have her serve as our General Counsel, as Clover will benefit from her healthcare expertise and deep understanding of our business as we continue to deliver on our mission,” said Toy.

Soares first joined Clover in 2018 as an Associate General Counsel, supporting the contracting, compliance, and product functions. She has served in many positions at the company since that time, most recently serving as Senior Vice President, Deputy General Counsel and successfully overseeing the company’s legal department on an interim basis. Prior to joining Clover, Soares held various legal and compliance positions with other organizations, including Analyte Health, a telehealth startup, and Fried, Frank, Harris, Shriver & Jacobson LLP. She received her B.A. from Dartmouth College, and her J.D. from the University of Chicago Law School.

“Over the past five years, I have had the privilege of working with the talented team at Clover as we work toward our mission to improve every life. I am honored and excited to step into the role of Clover’s General Counsel as we continue on this important journey,” Soares said.

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. Our Non-Insurance line of business similarly aims to reduce cost-of-care while enhancing the quality of care for patients enrolled in Original Medicare.

Press Contact:

Andrew Still-Baxter

Investor Relations Contact:

Ryan Schmidt



EN
01/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provide...

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull ...

 PRESS RELEASE

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcar...

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) i...

 PRESS RELEASE

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Re...

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Thursday, February 26, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter. Fourth Quarter and Full Year 2025 Conference Webcast Detail...

 PRESS RELEASE

Clover Health Announces 53% Growth in Medicare Advantage Membership Du...

Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026 Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong returning member retention, and improving cohort economics position Clover for compounding earnings and margin expansion.Powered by AI, Clover continues to bring industry-leading clinical quality to...

 PRESS RELEASE

Counterpart Health 2025 Results: How Better Clinical Decisions at Scal...

Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomes SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch